K50.9
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - Patients suffering from active inflammatory bowel disease and need to be treated with exclusive enteral nutrition therapy, steroids or biologicals; - Diagnosis confirmed by Porto diagnostic criteria; - informed consent of patients (> 12 years of age) and parents.
Exclusion criteria
Exclusion criteria: Changes in the immunosuppressive medication during the last three month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Parameters will be evaluated before and 2-6 weeks after initiation of therapy: 1. Gut microbiome composition before and during therapy (method: sequencing). 2. Mucosal inflammation on molecular and cellular level (methods: quantitative PCR, immunohistochemistry). 3. Phenotype and Function of peripheral blood mononuclear cells (methods: FACS analysis, ELISA, qPCR). | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical and laboratory remission after 2-6 weeks of therapy; methods: history and examination, disease activity score, stool and lab work for inflammatory markers; | — |
Countries
Germany
Contacts
Klinikum der Universität München, Dr. von Haunersches Kinderspital; Abteilung für pädiatrische Gastroenterologie und Hepatologie